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Abstract: A 53-year-old woman was referred urgently to the urol-
ogy department with a history of worsening right renal angle pain
and associated hematuria. Further investigations revealed the pres-
ence of a primary non-small cell lung cancer (NSCLC) invading the
posterior chest wall with an associated vaginal metastasis. To our
knowledge, this is only the second case report in the literature of a
vaginal metastasis from NSCLC.
(J Thorac Oncol. 2007;2: 671–672)
A 53-year-old postmenopausal woman presented to hergeneral practitioner with a 4-month history of worsening
right flank and renal angle pain. Urine dipstick confirmed the
presence of microscopic hematuria, but a midstream speci-
men of urine showed no evidence of infection. Her pain was
so severe that she was urgently admitted to the urology
department.
She had previously been very fit and well, with no
significant medical history. She was a smoker with a 20
pack/year history. Clinical examination was unremarkable
except for localized tenderness in her right upper quadrant.
Initial investigations including ultrasound of the abdomen
and intravenous pyelogram were entirely normal, but increas-
ing pain and the development of vaginal spotting prompted
further evaluation with contrast-enhanced computed tomog-
raphy (CT) of the thorax, abdomen, and pelvis. This revealed
a large right posterior chest wall mass that destroyed the
posterior aspects of the 9th to 11th ribs and invaded the
paravertebral muscles (Figure 1), and there was associated
mediastinal adenopathy. The liver and adrenals were normal,
and no other bony lesion was identified. However, a rim-
enhancing subepithelial mass was seen in the right lateral
wall of the vagina (Figure 2). Gynecological examination
confirmed the clinical presence of a subepithelial vaginal
mass, which was biopsied. An ultrasound-guided biopsy of
the chest wall mass was also performed.
Histopathological examination of the chest wall biopsy
specimen confirmed the presence of a poorly differentiated
carcinoma. Immunohistochemical staining was strongly pos-
itive for TTF-1, cytokeratin AE1/AE3, and epithelial mem-
brane antigen and was focally positive with p63. This profile
was highly suggestive of a non-small cell lung primary,
probably a squamous carcinoma in view of the p63 positivity.
The vaginal specimen also revealed a poorly differentiated
carcinoma with a microscopic appearance very similar to the
chest lesion. Immunostaining was again strongly positive for
TTF-1 and cytokeratin AE1/AE3 but was negative for cyto-
keratin 5, S-100, and estrogen receptor. These immunohisto-
chemical profiles, in association with the clinical and radio-
logical findings, led to a diagnosis of stage IV NSCLC with
a single vaginal metastasis (T3, N2, M1).
The patient received palliative radiotherapy to the chest
wall mass (17 Gy in two fractions, 1 week apart) for pain
relief, followed by four cycles of carboplatin and gemcitabine
chemotherapy. Despite significant symptomatic improvement
of both pain and vaginal bleeding, a repeat CT after the fourth
cycle of chemotherapy showed slight progression of the
disease. Because of her good performance status, she was
offered second-line chemotherapy with docetaxel, but the
patient felt so well and had good quality of life, so she
declined until symptomatic progression. Unfortunately, 6
months after initial diagnosis, the patient died of severe
pneumonia.
DISCUSSION
This case illustrates a very unusual presentation of
NSCLC. The pain from the posterior chest wall disease
associated with microscopic hematuria from the vaginal me-
tastasis prompted a clinical suspicion of renal tract pathology
and urgent referral to the urology department.
Most vaginal neoplasms are metastases or represent
direct extension from other genital tumors, e.g., cervical
cancer. After the ovary, the vagina is the second most
common site of metastases in the female genital tract.1 Most
vaginal metastases originate from other gynecological malig-
nancies, mainly endometrial carcinoma, whereas metastases
from extragenital cancers are uncommon. The most frequent
extragenital tumors that metastasize to the vagina are carci-
nomas of the rectum, colon, and breast. Other tumors re-
ported to metastasize to the vagina include malignant mela-
noma and cancers of the kidney, pancreas, and bladder. The
literature consists mainly of sporadic case reports. To our
knowledge, only one case of a vaginal metastasis from lung
cancer has previously been described, and this occurred on
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relapse of disease, not at presentation.2 Ours is the first
recorded case of lung cancer presenting with a vaginal me-
tastasis.
Primary vaginal cancer is rare, comprising only 2% to
3% of all gynecological malignancies. Of the cases, 80% to
90% are squamous cell carcinomas. Other cell types include
adenocarcinoma (5%–10%), sarcomas (3%), small cell car-
cinoma, and malignant melanoma.3
In this case, the lung and vaginal lesions were detected
synchronously. Although the possibility of a primary vaginal
cancer metastatic to the chest was considered, the immuno-
staining was extremely useful in confirming the pulmonary
origin of both the chest wall and vaginal lesions. In particular,
TTF-1 is a highly sensitive and specific marker for primary
lung cancer.4,5
In terms of clinical management, we noted that the
vaginal bleeding from the metastasis stopped soon after
commencement of systemic chemotherapy. A recent case
report has also described the successful use of external beam
radiotherapy to control bleeding from vaginal metastases.6
Cases of vaginal metastases from lung cancer may be
seen more frequently as the worldwide incidence of lung
cancer in women continues to increase and because the
routine use of fused positron emission tomography and com-
puted tomography (PET-CT) may identify asymptomatic
vaginal involvement.
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FIGURE 1. Contrast enhanced CT scan of the thorax show-
ing right chest wall invasion with rib destruction and para-
vertebral muscle involvement.
FIGURE 2. Contrast enhanced CT scan of the pelvis showing
a rim enhancing mass in the right lateral wall of the vagina.
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